168 related articles for article (PubMed ID: 37393309)
1. The lncRNA RMST is drastically downregulated in anaplastic thyroid carcinomas where exerts a tumor suppressor activity impairing epithelial-mesenchymal transition and stemness.
De Martino M; Pellecchia S; Esposito F; Liotti F; Credendino SC; Prevete N; Decaussin-Petrucci M; Chieffi P; De Vita G; Melillo RM; Fusco A; Pallante P
Cell Death Discov; 2023 Jul; 9(1):216. PubMed ID: 37393309
[TBL] [Abstract][Full Text] [Related]
2. The Long Non-Coding RNA
Pellecchia S; Sepe R; Decaussin-Petrucci M; Ivan C; Shimizu M; Coppola C; Testa D; Calin GA; Fusco A; Pallante P
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31963578
[TBL] [Abstract][Full Text] [Related]
3. Transcript-level regulation of MALAT1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.
Samimi H; Haghpanah V; Irani S; Arefian E; Sohi AN; Fallah P; Soleimani M
Daru; 2019 Jun; 27(1):1-7. PubMed ID: 31077090
[TBL] [Abstract][Full Text] [Related]
4. OVOL2 impairs RHO GTPase signaling to restrain mitosis and aggressiveness of Anaplastic Thyroid Cancer.
Gugnoni M; Manzotti G; Vitale E; Sauta E; Torricelli F; Reggiani F; Pistoni M; Piana S; Ciarrocchi A
J Exp Clin Cancer Res; 2022 Mar; 41(1):108. PubMed ID: 35337349
[TBL] [Abstract][Full Text] [Related]
5. LncRNA-RMST Functions as a Transcriptional Co-regulator of SOX2 to Regulate miR-1251 in the Progression of Hirschsprung's Disease.
Zhou L; Zhi Z; Chen P; Du C; Wang B; Fang X; Tang W; Li H
Front Pediatr; 2022; 10():749107. PubMed ID: 35321017
[TBL] [Abstract][Full Text] [Related]
6. The long noncoding RNA RMST interacts with SOX2 to regulate neurogenesis.
Ng SY; Bogu GK; Soh BS; Stanton LW
Mol Cell; 2013 Aug; 51(3):349-59. PubMed ID: 23932716
[TBL] [Abstract][Full Text] [Related]
7. Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer.
Morrison JA; Pike LA; Sams SB; Sharma V; Zhou Q; Severson JJ; Tan AC; Wood WM; Haugen BR
Mol Cancer; 2014 Mar; 13():62. PubMed ID: 24645981
[TBL] [Abstract][Full Text] [Related]
8. The long non-coding RNA rhabdomyosarcoma 2-associated transcript exerts anti-tumor effects on lung adenocarcinoma via ubiquitination of
Pei Y; Zhou B; Liu X
Ann Transl Med; 2022 Jan; 10(1):10. PubMed ID: 35242855
[TBL] [Abstract][Full Text] [Related]
9. Expression of cancer stem cell markers and epithelial-mesenchymal transition-related factors in anaplastic thyroid carcinoma.
Jung CW; Han KH; Seol H; Park S; Koh JS; Lee SS; Kim MJ; Choi IJ; Myung JK
Int J Clin Exp Pathol; 2015; 8(1):560-8. PubMed ID: 25755746
[TBL] [Abstract][Full Text] [Related]
10. Tumor-related Molecular Regulatory Mechanisms of Long Non-coding RNA RMST: Recent Evidence.
Chen X; Liu K; Xu W; Zhou G; Yuan C
Mini Rev Med Chem; 2022; 22(10):1374-1379. PubMed ID: 34856896
[TBL] [Abstract][Full Text] [Related]
11. Targeting DEP domain containing 1 in anaplastic thyroid carcinoma: Implications for stemness regulation and malignant phenotype suppression.
Zhu C; Ke S; Li Y; Zhang W; Che Y; Zhang R; Huang P; Xu T
Heliyon; 2024 Mar; 10(5):e27150. PubMed ID: 38449652
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of long non-coding RNAs in anaplastic thyroid cancer: a systematic review.
Samimi H; Sajjadi-Jazi SM; Seifirad S; Atlasi R; Mahmoodzadeh H; Faghihi MA; Haghpanah V
Cancer Cell Int; 2020; 20():352. PubMed ID: 32760219
[TBL] [Abstract][Full Text] [Related]
13. Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer.
Haghpanah V; Fallah P; Tavakoli R; Naderi M; Samimi H; Soleimani M; Larijani B
Tumour Biol; 2016 Jan; 37(1):1299-308. PubMed ID: 26289851
[TBL] [Abstract][Full Text] [Related]
14. Long Non-coding RNA Rhabdomyosarcoma 2-Associated Transcript Regulates Angiogenesis in Endothelial Cells.
Alaqeeli M; Mayaki D; Hussain SNA
Front Physiol; 2021; 12():729157. PubMed ID: 34744768
[No Abstract] [Full Text] [Related]
15. lncRNA RMST Suppressed GBM Cell Mitophagy through Enhancing FUS SUMOylation.
Liu C; Peng Z; Li P; Fu H; Feng J; Zhang Y; Liu T; Liu Y; Liu Q; Liu Q; Li D; Wu M
Mol Ther Nucleic Acids; 2020 Mar; 19():1198-1208. PubMed ID: 32069702
[TBL] [Abstract][Full Text] [Related]
16. Long Non-coding RNA Expression in Anaplastic Thyroid Carcinomas.
Wang Y; Hardin H; Chu YH; Esbona K; Zhang R; Lloyd RV
Endocr Pathol; 2019 Dec; 30(4):262-269. PubMed ID: 31468286
[TBL] [Abstract][Full Text] [Related]
17. Novel role of ASH1L histone methyltransferase in anaplastic thyroid carcinoma.
Xu B; Qin T; Yu J; Giordano TJ; Sartor MA; Koenig RJ
J Biol Chem; 2020 Jun; 295(26):8834-8845. PubMed ID: 32398261
[TBL] [Abstract][Full Text] [Related]
18. Roles of Non-Coding RNAs on Anaplastic Thyroid Carcinomas.
Das PK; Asha SY; Abe I; Islam F; Lam AK
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33126409
[TBL] [Abstract][Full Text] [Related]
19. SRY‑related HMG box‑2 role in anaplastic thyroid cancer aggressiveness is related to the fibronectin 1 and PI3K/AKT pathway.
Wang P; Shang J; Zhao J; Wang K; Guo L; Gu J; Wang W
Mol Med Rep; 2020 Mar; 21(3):1201-1207. PubMed ID: 31922212
[TBL] [Abstract][Full Text] [Related]
20. The mutation profile of differentiated thyroid cancer coexisting with undifferentiated anaplastic cancer resembles that of anaplastic thyroid cancer but not that of archetypal differentiated thyroid cancer.
Mika J; Łabaj W; Chekan M; Abramowicz A; Pietrowska M; Polański A; Widłak P
J Appl Genet; 2021 Feb; 62(1):115-120. PubMed ID: 33222100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
